Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 38 | 132 | 87 | 0 |
| Gross Profit | N/A | 38 | 132 | 87 | N/A |
| Operating Expenses | 10,559 | 20,943 | 14,552 | 15,858 | 26,642 |
| Operating Income | -10,559 | -20,905 | -14,421 | -15,771 | -26,642 |
| Interest Expense | 30 | 31 | 15 | 16 | 11 |
| Other Income | 21 | 280 | 148 | 75 | 222 |
| Pre-tax Income | -10,568 | -20,656 | -14,288 | -15,712 | -26,431 |
| Net Income Continuous | -10,568 | -20,656 | -14,288 | -15,712 | -26,431 |
| Net Income | $-10,568 | $-20,656 | $-14,288 | $-15,712 | $-26,431 |
| EPS Basic Total Ops | -48.05 | -275.68 | -213.51 | -242.94 | -845.16 |
| EPS Basic Continuous Ops | -47.92 | -275.69 | -213.58 | -242.83 | -840.74 |
| EPS Diluted Total Ops | -48.05 | -275.68 | -213.51 | -242.94 | -845.16 |
| EPS Diluted Continuous Ops | -47.92 | -275.69 | -213.58 | -242.83 | -840.74 |
| EPS Diluted Before Non-Recurring Items | -48.05 | -275.68 | -213.51 | -251.75 | -845.16 |
| EBITDA(a) | $-10,559 | $-20,878 | $-14,376 | $-15,730 | $-26,590 |